These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6803060)

  • 21. Primary cadaver kidney transplant survival after donor pretreatment with cyclophosphamide and methylprednisolone.
    Barry JM; Bennett WM
    Transplantation; 1978 Sep; 26(3):202-3. PubMed ID: 360520
    [No Abstract]   [Full Text] [Related]  

  • 22. Attempted immunological alteration of canine renal allograft donors.
    Zincke H; Woods JE
    Transplantation; 1974 Dec; 18(6):480-6. PubMed ID: 4612885
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined effect of recipient blood transfusion and donor pretreatment with cyclophosphamide and methylprednisolone.
    Corry RJ; West JC
    Transplant Proc; 1981 Mar; 13(1 Pt 1):161-3. PubMed ID: 7022814
    [No Abstract]   [Full Text] [Related]  

  • 24. Orthotopic liver transplantation. Various immunosuppressive regimens to improve survival.
    Toledo-Pereyra LH; Bandlien KO; MacKenzie GH; Gordon DA
    Am Surg; 1984 May; 50(5):258-63. PubMed ID: 6372562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination drug treatment in immunosuppression. Effect of azathioprine, cyclophosphamide, and methylprednisolone on rabbit renal allografts.
    Friedman EA; Ueno A; Beyr MM; Nicastri AD
    Transplantation; 1973 Jun; 15(6):619-23. PubMed ID: 4577157
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
    Toledo-Pereyra LH; Condie RM
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor pretreatment on perfused cadaver kidneys: experimental observations.
    Sy G; Taiyebb S; Toledo-Pereyra LH
    Am Surg; 1981 Jul; 47(7):307-8. PubMed ID: 7020513
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro alteration of canine renal allografts with cyclophosphamide metabolites.
    Zincke H; Jardine I; Colvin M; Aydin G; Okiye SE
    Transplant Proc; 1983 Jun; 15(2):1698-701. PubMed ID: 6349051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statewide donor pretreatment study.
    Dienst SG
    Transplant Proc; 1977 Sep; 9(3):1597-9. PubMed ID: 331595
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternative applications of cyclosporin A to improve kidney allograft survival.
    Toledo-Pereyra LH; Mackenzie GH; Gordon DA; Gof S; Bandlien K
    J Urol; 1984 Apr; 131(4):777-80. PubMed ID: 6368871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro alteration of canine renal allograft immunogenicity.
    Waltzer WC; Zincke H; Sterioff S; Holley KE; Offord KP; Matsuura JK
    Transplantation; 1980 Mar; 29(3):249-51. PubMed ID: 6987791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor pretreatment as an adjunct to cadaveric renal transplantation--update 1979.
    Guttmann RD; Morehouse DD; Meakins JL; Milne CA; Knaack J
    Transplant Proc; 1980 Jun; 12(2):341-7. PubMed ID: 6994304
    [No Abstract]   [Full Text] [Related]  

  • 34. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
    Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
    J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetics of kidney allograft survival in dogs. III. Relevance of histocompatibility matching in immunosuppressed recipients.
    Bijnen AB; Obertop H; Joling P; Westbroek DL
    Transplantation; 1980 Sep; 30(3):191-5. PubMed ID: 14582175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative preparation of high-risk, specifically hyperimmunized canine renal allograft recipients with total-lymphoid irradiation and cyclosporine.
    Rapaport FT; Meek AG; Arnold AN; Miura S; Hayashi R; Strober S
    Transplantation; 1987 Aug; 44(2):185-95. PubMed ID: 3307042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of transfusions and donor pretreatment on canine renal allograft survival.
    van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H
    J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolongation of allograft and xenograft survival by pretreatment with prednisolone and donor-specific antigen.
    Lie TS
    Surg Gynecol Obstet; 1976 Sep; 143(3):369-75. PubMed ID: 60786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL; Jones DB; Yenikomshian A; DeVoe C; DeRito J
    Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment of cadaver donors with cyclophosphamide and methylprednisolone: effect on renal transplant outcome.
    Corry RJ; Patel NP; West JC; Schanbacher BA
    Transplant Proc; 1980 Jun; 12(2):348-51. PubMed ID: 6994305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.